Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
bio365 is an agricultural biotechnology company that develops and manufactures patented, biologically activated biochar-based growing media for controlled environment agriculture (CEA). Founded in 2015 and headquartered in Ithaca, New York, the company provides engineered soil solutions designed to optimize plant health, increase yields, and enhance the expression of cannabinoids and terpenes in medicinal crops like cannabis and hemp. Its core technologies, bioCHARGE and bioCORE, utilize a proprietary process to integrate beneficial microbiology with high-carbon biochar, creating a stable and nutrient-rich substrate. bio365's products are used by large-scale commercial growers and have been recognized for their scientific innovation, including being the first engineered soil used for research on the International Space Station.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on bio365.